How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease. Full Text available with Trip Pro

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease. We evaluated the validity and reliability of multiple symptom scales for depression and anxiety for persons with inflammatory bowel disease (IBD).IBD participants in a cohort study completed a Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed the Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Kessler-6 (...) Distress Scale, PROMIS Emotional Distress Depression Short-Form 8a (PROMIS Depression) and Anxiety Short-Form 8a (PROMIS Anxiety), Generalized Anxiety Disorder 7-item Scale, and Overall Anxiety and Severity Impairment Scale. We computed sensitivity, specificity, and positive and negative predictive values for the screening measures with the SCID diagnoses as the reference standard, conducted receiver operating curve (ROC) analysis, and assessed internal consistency and test-retest reliability.Of 242

2018 Inflammatory Bowel Diseases

62. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study. Full Text available with Trip Pro

screening tools. We investigated if MetS has an impact on the accuracy of current major depressive disorder (MDD) and generalized anxiety disorder (GAD) screening results using the Hospital Anxiety and Depression scale (HADS).A total of 1115 (562 men; mean age 62.0 ± 9.6 years) individuals of 45+ years of age were randomly selected from the general population and evaluated for current MetS; depressive and anxiety symptoms (HADS); and current MDD and GAD (Mini International Neuropsychiatric Interview (...) %, specificity = 78% and PPV = 38%). At threshold of ≥9 the HADS-Anxiety subscale demonstrated optimal psychometric properties for current GAD screening in individuals with MetS (sensitivity = 91%, specificity = 85% and PPV = 72%) and without MetS (sensitivity = 84%, specificity = 83% and PPV = 56%).The HADS is a reliable screening tool for current MDE and GAD in middle aged and elderly population with and without MetS. Optimal thresholds of the HADS-Depression subscale for current MDD is ≥9 for individuals

2018 BMC Psychiatry

63. Depression in cirrhosis - a prospective evaluation of the prevalence, predictors and development of a screening nomogram. (Abstract)

. Prevalence of depression 18% by MINI. Patients with depression had lower baseline HRQoL and higher frailty scores. Five independently predictive factors were used to develop a clinical nomogram for the diagnosis of clinical depression. These included three Hospital Anxiety and Depression Screening tool variables: "I have lost interest in my appearance" (adjusted odds ratio [aOR] 2.2, P = 0.006), "I look forward with enjoyment to things" (aOR 2.0, P = 0.02), "I feel cheerful" (aOR 2.8, P = 0.002), and two (...) Depression in cirrhosis - a prospective evaluation of the prevalence, predictors and development of a screening nomogram. Depression is associated with substantial morbidity and mortality in cirrhosis, but is underdiagnosed and undertreated.Using the Mini International Neuropsychiatric Interview (MINI) as a gold-standard, to determine prevalence, predictors, and outcomes of depression, and to develop a screening nomogram for use in cirrhosis patients.Cirrhotic outpatients 18-80 years of age

2018 Alimentary Pharmacology & Therapeutics

64. Opportunities and obstacles to screening for perinatal depression among women in Zimbabwe: A narrative review of literature Full Text available with Trip Pro

for depression screening are possible because of the high antenatal and postnatal service coverage, the potential for universal screening is fraught with human and financial resource constraints, lack of training in mental health care among primary health care providers and lack of locally validated screening tools for depression.There is a need to channel resources into the training of midwives and other primary health care providers on mental health issues affecting women perinatally. (...) Opportunities and obstacles to screening for perinatal depression among women in Zimbabwe: A narrative review of literature The perinatal period provides an opportune time for health care providers to screen for and proffer interventions for women suffering from depression. However, routine screening for depression is not done in primary care settings in Zimbabwe.This narrative review discusses opportunities and obstacles surrounding screening for perinatal depression in primary care settings

2018 The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa

65. Screening for Executive Dysfunction in Late-Life Depression: Utility of Trail Making Test and Self-Report Measures. (Abstract)

Screening for Executive Dysfunction in Late-Life Depression: Utility of Trail Making Test and Self-Report Measures. Prior work suggests executive dysfunction (ED) on the Stroop Color and Word Test (SCWT) and the Mattis Dementia Rating Scale-2 Initiation/Perseveration subscale (DRS IP) predicts poor antidepressant response in late-life depression. This study examined if either patient perception of ED or the Trail Making Test Part B (TMT-B) could identify patients with impairment on the SCWT (...) -reports are useful screening tools for ED on the SCWT or DRS IP.Copyright © 2018 Elsevier Ltd. All rights reserved.

2018 The American Journal of Geriatric Psychiatry

66. Development and Validation of an Item Bank for Depression Screening in the Chinese Population Using Computer Adaptive Testing: A Simulation Study Full Text available with Trip Pro

Development and Validation of an Item Bank for Depression Screening in the Chinese Population Using Computer Adaptive Testing: A Simulation Study With the increasing prevalence of depression, creating a simple and precise tool for measuring depression is becoming more important. This study developed a computer adaptive testing for depression (CAT-Depression) from a Chinese sample. The depression item bank was constructed from a sample of 1,135 participants with or without depression using (...) the Graded Response Model (GRM; Samejima, 1969). The final depression item bank with strict unidimensionality comprised 68 items, which had local independence, good item-fit, high discrimination, no differential item functioning (DIF), and each item measured at least one symptom of diagnostic criteria for depression in ICD-10. In addition, the mean IRT discrimination of the item bank reached 1.784, which clearly showed that the item bank of CAT-Depression was high-quality. Moreover, a simulation CAT

2018 Frontiers in psychology

67. Implementation of depression and anxiety screening in patients undergoing radiotherapy Full Text available with Trip Pro

Implementation of depression and anxiety screening in patients undergoing radiotherapy Anxiety and depression are disabling, underdiagnosed issues that affect the management of oncology patients. Until recently, there has been no standard protocol for screening and treating these ailments at our cancer centre. The purpose of this institutional review board-approved study was to analyse the implementation of a screening tool in our clinical workflow with the aim of screening over 90% of patients

2018 BMJ Open Quality

68. Depression screening and education: an examination of mental health literacy and stigma in a sample of Hispanic women. Full Text available with Trip Pro

likely to follow a treatment plan compared to non-Hispanic whites. Hispanic women are more likely to access treatment through a primary care provider, making it an ideal setting for early mental health interventions.Baseline data from 319 female Hispanic patients enrolled in Project DESEO: Depression Screening and Education: Options to Reduce Barriers to Treatment, were examined. The study implemented universal screening with a self-report depression screening tool (the 9-item Patient Health (...) Depression screening and education: an examination of mental health literacy and stigma in a sample of Hispanic women. Mental health literacy consists of knowledge of a mental disorder and of the associated stigma. Barriers to depression treatment among Hispanic populations include persistent stigma which is primarily perpetuated by inadequate disease literacy and cultural factors. U.S.-born Hispanics are more likely to have depression compared to Hispanics born in Latin America and are less

2018 BMC Public Health

69. Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder

Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03716869 Recruitment Status : Enrolling by invitation First Posted : October 23, 2018 Last Update Posted : February 6, 2019 Sponsor: Milton S. Hershey Medical Center

2018 Clinical Trials

70. Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer Guideline Adaptation Full Text available with Trip Pro

Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer Guideline Adaptation Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLES Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2013.52.4611 Journal of Clinical Oncology (...) - published online before print April 14, 2014 PMID: Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation x Barbara L. Andersen , x Robert J. DeRubeis , x Barry S. Berman , x Jessie Gruman , x Victoria L. Champion , x Mary Jane Massie , x Jimmie C. Holland , x Ann H. Partridge , x Kate Bak , x Mark R. Somerfield , x Julia H. Rowland Barbara L. Andersen, The Ohio State University, Columbus, OH; Robert J

2014 American Society of Clinical Oncology Guidelines

71. Efficacy and safety of screening for postpartum depression

for the HTA database. Citation Myers ER, Aubuchon-Endsley N, Bastian LA, Gierisch JM, Kemper AR, Swamy GK, Wald MF, McBroom AJ, Lallinger KR, Gray RN, Green C, Sanders GD. Efficacy and safety of screening for postpartum depression. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 106. 2013 Authors' objectives To describe the benefits and harms of specific tools and strategies for screening for postpartum depression. Authors' conclusions The potential (...) Efficacy and safety of screening for postpartum depression Efficacy and safety of screening for postpartum depression Efficacy and safety of screening for postpartum depression Myers ER, Aubuchon-Endsley N, Bastian LA, Gierisch JM, Kemper AR, Swamy GK, Wald MF, McBroom AJ, Lallinger KR, Gray RN, Green C, Sanders GD Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made

2013 Health Technology Assessment (HTA) Database.

72. Validating the Edinburgh Postnatal Depression Scale as a screening tool for postpartum depression in Kathmandu, Nepal Full Text available with Trip Pro

Validating the Edinburgh Postnatal Depression Scale as a screening tool for postpartum depression in Kathmandu, Nepal Edinburgh Postnatal Depression Scale (EPDS) is considered well accepted screening tool for postpartum depression (PPD). The objective of the study was to validate the EPDS as a screening tool for postpartum depression in Kathmandu, Nepal.A hospital based cross sectional study using EPDS was conducted among 346 mothers between 4 and 14 weeks of postpartum period. All (...) and negative predictive value of the Nepalese version EPDS was found to be 92, 95.6, 77 and 99.3 % respectively. The best cut-off point of EPDS for screening of PPD was found to be 12/13 and the area of the curve was 0.98 (95 % CI 0.970-0.994, p = 0.001).The prevalence of PPD is not that far from the previous studies of Nepal. Nepali version of EPDS was acceptable and the study demonstrates good validity, thus EPDS can be used as valid screening tool for PPD for early detection, prompt treatment

2016 International journal of mental health systems

73. Screening Tools to Identify Adults with Cognitive Impairment Associated with Dementia

Screening Tools to Identify Adults with Cognitive Impairment Associated with Dementia TITLE: Screening Tools to Identify Adults with Cognitive Impairment Associated with Dementia: Diagnostic Accuracy DATE: 18 November 2014 RESEARCH QUESTION What is the diagnostic accuracy of screening tools to identify adults with cognitive impairment associated with dementia? KEY FINDINGS Nine systematic reviews and meta-analyses, and 43 non-randomized studies were identified regarding the diagnostic accuracy (...) of screening tools to identify adults with cognitive impairment associated with dementia. No relevant randomized controlled trials were identified. METHODS A limited literature search was conducted on key resources including Medline, PubMed, The Cochrane Library (2014, Issue 10), University of York Centre for Reviews and Dissemination (CRD) databases, Canadian and major international health technology agencies, as well as a focused Internet search. Methodological filters were applied to limit retrieval

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

74. Depression: Perinatal

antidepressant in pregnancy. The first-line antidepressant in both pregnancy and lactation is sertraline and second-line is escitalopram. Fluoxetine is not recommended. Previously, sertraline was first-line and citalopram and fluoxetine were second-line antidepressants for pregnancy and lactation. Escitalopram was not on the preferred list. For pregnant and postpartum women, we now recommend using the Maternal Behavioral Health Screening tool. Previously, depression screening for all adults was done (...) initiative that focuses on pregnant and postpartum women through an infant’s first year of life. Recent research demonstrates that pregnancy and the first year of the infant's life pose increased risks to the mother's mental health and well-being, including depression, anxiety, and domestic violence. MBH screening tools and processes are similar to those used in BHI, but they are tailored for maternal health and include questions about domestic violence. 3 Screening and Diagnosis Routine screening using

2020 Kaiser Permanente Clinical Guidelines

75. Improving discrimination in antepartum depression screening using the Edinburgh Postnatal Depression Scale. (Abstract)

Improving discrimination in antepartum depression screening using the Edinburgh Postnatal Depression Scale. Universal screening of pregnant women for postpartum depression has recently been recommended; however, optimal application of depression screening tools in stratifying risk has not been defined. The current study examines new approaches to improve the ability of the Edinburgh Postnatal Depression Scale (EPDS) to stratify risk for postpartum depression, including alternate cut points, use (...) of a continuous measure, and incorporation of other putative risk factors.An observational cohort study of 4939 women screened both antepartum and postpartum with a negative EPDS screen antepartum(i.e. EPDS<10). The primary outcome was a probable postpartum major depressive episode(EPDS cut-off ≥10). Area under the receiver operating characteristics curve(AUC), sensitivity, specificity, and predictive values were calculated.287 women(5.8%) screened positive for postpartum depression. An antepartum EPDS cut

2017 Journal of Affective Disorders

76. Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Full Text available with Trip Pro

criteria, the tools used in the studies (e.g. semi-structured psychiatric interview and psychometric questionnaires), as well as the stage and type of cancer. Furthermore, despite the significant health care resources devoted to cancer care and the importance of addressing depressive symptoms, assessment and management of depressive spectrum disorders in cancer patients remains suboptimal.Routine screening and adequate assessment of depressive spectrum disorders is necessary in patients with cancer (...) Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Although depression and mood-related disorders are common in persons with cancer, these conditions remain frequently overlooked in clinical practice. Negative consequences of depressive disorder spectrum have been reported (e.g. suicidal ideation, increase physical complications and somatic symptoms, negative influence on prognosis), indicating the need for routine screening

2017 Acta Oncologica

77. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Full Text available with Trip Pro

The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Depression screening in patients with cancer is recommended by major clinical guidelines, although the evidence on individual screening tools is limited for this population. Here, the authors assess and compare the diagnostic accuracy of 2 established screening instruments: the depression modules of the 9-item Patient Health (...) Questionnaire (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS-D), in a representative sample of patients with cancer.This multicenter study was conducted with a proportional, stratified, random sample of 2141 patients with cancer across all major tumor sites and treatment settings. The PHQ-9 and HADS-D were assessed and compared in terms of diagnostic accuracy and receiver operating characteristic (ROC) curves for Diagnostic and Statistical Manual of Mental Disorders, 4th edition diagnosis

2017 Cancer

78. Screening Family and Psychosocial Risk in Pediatric Migraine and Tension-Type Headache: Validation of the Psychosocial Assessment Tool (PAT). Full Text available with Trip Pro

functioning (r = .21). Predictive validity was demonstrated by a significant association between PAT Total scores at baseline with child emotional and behavioral functioning (r = .64), parent anxiety (r = .37), parent depression (r = .42), and family functioning (r = .26) at 6-month follow-up.The PAT is a promising tool for screening psychosocial risk that could facilitate identification of psychosocial treatment needs among youth with recurrent headache at risk for poor outcomes.© 2019 American Headache (...) Screening Family and Psychosocial Risk in Pediatric Migraine and Tension-Type Headache: Validation of the Psychosocial Assessment Tool (PAT). To present data on psychometric properties of the Psychosocial Assessment Tool 2.0_General (PAT), a brief screener for psychosocial risk in families of youth with medical conditions, in youth with headache.Emotional and behavioral disturbances, parent distress, and poor family functioning are common among youth with recurrent migraine and tension-type

2019 Headache

79. Development and validation of a simple screening tool for caregiver grief in dementia caregiving. Full Text available with Trip Pro

Development and validation of a simple screening tool for caregiver grief in dementia caregiving. Loss and grief are experienced by caregivers of persons with dementia (PWD), relating to the ambiguous loss of PWD even when they are still alive and the anticipation of future loss related to their physical death. Such experience of caregiver grief is not easily recognized in clinical practice, despite its association with adverse effects such as caregiver burden, caregiver depression (...) and caregivers' desire to place the PWD in nursing homes. We constructed a simple screening tool - based on factors associated with caregiver grief - to identify caregivers with high grief.Spouses or children of community-dwelling PWD (n = 403) completed self-administered questionnaires containing a well-established grief scale and information related to the caregiver and PWD. We split the study sample into two - the derivation sample (n = 300) was used to identify factors associated with grief (using

2019 BMC Geriatrics

80. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder. (Abstract)

Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder. This study evaluated the association between self-reported anxiety and objective/subjective measures of cognitive performance in adults with Major Depressive Disorder (MDD).Acutely depressed subjects with recurrent MDD (n = 100) and age-, sex-, and education-matched healthy controls (HC; n = 100) between the ages of 18 and 65 completed the cross (...) -sectional validation study of the THINC-integrated tool (THINC-it; ClinicalTrials.gov: NCT02508493). Objective cognitive performance was assessed using the THINC-it, and subjective cognitive impairment with the Perceived Deficits Questionnaire for Depression-5-item. Subjects also completed the Generalized Anxiety Disorder-7-item (GAD-7) questionnaire.Subjects with MDD reported significantly more anxiety symptoms, as assessed by the GAD-7, compared to HC (p < 0.001). Linear regression analysis determined

2018 Journal of Affective Disorders

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>